The year 2021 in the European Heart Journal-Cardiovascular Imaging: Part I.

cardiac magnetic resonance (CMR) computer tomography (CT) echocardiography multimodality imaging nuclear

Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
17 11 2022
Historique:
received: 26 09 2022
accepted: 28 09 2022
pubmed: 30 10 2022
medline: 22 11 2022
entrez: 29 10 2022
Statut: ppublish

Résumé

The European Heart Journal-Cardiovascular Imaging was introduced in 2012 and has during these 10 years become one of the leading multimodality cardiovascular imaging journals. The journal is currently ranked as Number 19 among all cardiovascular journals. It has an impressive impact factor of 9.130 and our journal is well established as one of the top cardiovascular journals. The most important studies published in our Journal in 2021 will be highlighted in two reports. Part I of the review will focus on studies about myocardial function and risk prediction, myocardial ischaemia, and emerging techniques in cardiovascular imaging, while Part II will focus on valvular heart disease, heart failure, cardiomyopathies, and congenital heart disease.

Identifiants

pubmed: 36308337
pii: 6779868
doi: 10.1093/ehjci/jeac210
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1576-1583

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Conflict of interest: None declared.

Auteurs

Thor Edvardsen (T)

Department of Cardiology, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, Postbox 4950 Nydalen, NO-0424 Oslo, Norway.
Institute for Clinical Medicine, University of Oslo, Sognsvannsveien 20, NO-0424 Oslo, Norway.

Erwan Donal (E)

Department of Cardiology and CIC-IT1414, CHU Rennes, Inserm, LTSI-UMR 1099, University Rennes-1, Rennes F-35000, France.

Denisa Muraru (D)

Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Piazzale Brescia 20, 20149 Milan, Italy.
Department of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy.

Alessia Gimelli (A)

Imaging Department, Fondazione Toscana G. Monasterio, Via Giuseppe Moruzzi, 1, 56124 Pisa PI, Italy.

Ricardo Fontes-Carvalho (R)

Cardiology Department, Centro Hospitalar de Vila Nova de Gaia/Espinho, R. Dr. Francisco Sá Carneiro 4400-129, 4430-999 Vila Nova de Gaia, Portugal.
Cardiovascular R&D Centre - UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Alameda Prof. Hernâni Monteiro 4200-319 Porto, Portugal.

Gerald Maurer (G)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Wahringer Gurtel 18-20, 1090 Vienna, Austria.

Steffen E Petersen (SE)

Barts Heart Centre, Barts Health NHS Trust, West Smithfield, London EC1A 7BE, UK.
William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.

Bernard Cosyns (B)

Department of Cardiology, CHVZ (Centrum voor Hart en Vaatziekten), ICMI (In Vivo Cellular and Molecular Imaging) Laboratory, Universitair ziekenhuis Brussel, 1090 Jette, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH